Home Cart Sign in  
Chemical Structure| 1391076-61-1 Chemical Structure| 1391076-61-1

Structure of GLPG0974
CAS No.: 1391076-61-1

Chemical Structure| 1391076-61-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GLPG0974 is a free fatty acid receptor-2 (FFA2/GPR43) antagonist with an IC50 of 9 nM.

Synonyms: GLPG0974

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GLPG0974

CAS No. :1391076-61-1
Formula : C25H25ClN2O4S
M.W : 485.00
SMILES Code : O=C(O)CCCN(C([C@]1(C)N(C(C2=CSC3=CC=CC=C32)=O)CC1)=O)CC4=CC=CC(Cl)=C4
Synonyms :
GLPG0974
MDL No. :MFCD28502087

Safety of GLPG0974

Related Pathways of GLPG0974

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01496937 Healthy Phase 1 Completed - Belgium ... More >> SGS Stuivenberg Antwerp, Belgium Less <<
NCT01829321 Ulcerative Colitis Phase 2 Completed - Belgium ... More >> Imelda Bonheiden, Belgium UZ Gent Gent, Belgium AZ Groeninge Kortrijk, Belgium UZ Leuven Leuven, Belgium Czech Republic Hepato-Gastroenterologie HK, s.r.o. Hradec Kralove, Czech Republic Fakulní nemocnice Olomouc Olomouc, Czech Republic Homolka Hospitál Prague, Czech Republic Nemocnice Slaný Slany, Czech Republic Krajská zdravotní a.s., Masarykova nemocnice v Ústí nad Labem T. Bati a.s. Usti nad Labem, Czech Republic Krajská nemocnice Tomáše Bati - Zlin Zlin, Czech Republic Nemocnice Znojmo Znojmo, Czech Republic Latvia Latvijas Jūras Medicīnas Centrs Riga, Latvia Rīgas slimnīca Bikor Holim Riga, Latvia SIA Gremošanas slimību centrs "Gastro" Riga, Latvia Slovakia Univerzitná nemocnica Bratislava Bratislava, Slovakia Fakultná Nemocnica Nitra Nitra, Slovakia Less <<
NCT01721980 Healthy Phase 1 Completed - Belgium ... More >> SGS LSS Clinical Pharmacology Unit Antwerp Antwerp, Belgium Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.31mL

2.06mL

1.03mL

20.62mL

4.12mL

2.06mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories